Blanket Purchase Agreement HHSN263200200056682B

This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), to MBL International Corporation, a for-profit manufacturer of goods. The BPA covers the procurement of blood/blood products, biological materials, and chemicals. The BPA has no set-aside and was originally awarded on July 11, 2002, with an open-ended potential value. Under this BPA, three task orders have been issued to date. The first, awarded on December...

This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Worthington Biochemical Corp, a for-profit manufacturer. The $50,000,000.00 single-award contract has a period of performance from March 21, 2024 to April 30, 2026. The BPA is for the procurement of biological materials, blood/blood products, laboratory supplies, and chemicals. No set-asides were used. The BPA allows the agency to issue task orders against the...

This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Southern Biotechnology Associates Inc. as a single award contract with a ceiling value of $100,000,000 and a period of performance through August 31, 2025. The BPA is intended to procure operation and maintenance items including chemicals, blood/blood products, biological materials and media, and animal services. The broad scope of the contract suggests it may...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) contract to Phoenix Pharmaceuticals, Inc., a minority-owned, for-profit Asian-Pacific American manufacturer of goods. The contract is for the procurement of BIOLOGICAL MATERIALS, BLOOD/BLOOD PRODUCTS with a potential value of $0.00 and a period of performance ending on May 31, 2024. As a BPA, this is a single-award...

This Blanket Purchase Agreement (BPA) was awarded by the National Institutes of Health (NIH) to Bioivt, LLC, a leading global provider of high-quality biological specimens and value-added services. The $1 billion BPA has a period of performance from May 2023 to January 2026 and is for the procurement of biological materials, blood, and blood products in support of medical research programs across federal agencies. Through this IDV, Bioivt will provide a variety of biological materials, including...

This Blanket Purchase Agreement (BPA) is a federal contract Indefinite Delivery Vehicle (IDV) awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to the prime contractor Lofstrand Labs LTD. The contract has a ceiling value of $10,000,000.00 and a period of performance through July 31, 2025. The BPA is for the procurement of biological materials and blood/blood products for operations and maintenance. No set-asides were used. The contract aims to provide the agency...

This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Office of the Director, a civilian federal agency, to Biosource International Incorporated. The BPA covers the procurement of various biological materials, chemicals, blood products, and media, with a handling charge of $15.00 for sensitive materials. The period of performance for the BPA is from February 25, 2005 to September 30, 2011, with no stated ceiling value. The task orders under this BPA include the...

The National Institutes of Health Office of Logistics and Acquisition Operations awarded a single-award blanket purchase agreement to Biopool US, Inc., doing business as Trinity Biotech Distribution, on February 2, 2016 to procure blood, biological materials, medical equipment, and scientific instruments. The BPA has a potential value of $0 and expires on February 7, 2024. Through past task orders, the BPA has provided hemoglobin A1c analyzers, test kits, reagents, quality controls, and...

This Blanket Purchase Agreement (BPA) was awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Deutschland GMBH, a German-based company that specializes in providing advanced medical and laboratory products and services to the U.S. federal government, particularly the Department of Defense. The $2 million BPA, awarded on August 1, 2024, has a period of performance through July 31, 2026. It is intended to supply laboratory items, including reagents, medical supplies, and equipment,...

The Defense Health Agency awarded a single-award blanket purchase agreement to Hcsc Blood Center, operating as Miller-Keystone Blood Center, to supply blood products in support of healthcare programs. With a potential value of $6 million, the BPA enables ordering of blood components such as red blood cells, frozen plasma, and platelets through February 2025 at locations to be determined. No set-aside provisions were applied under the terms of this IDV, reflecting the Agency's need to fulfill its...